Repligen Corporation (Nasdaq: RGEN) announced that it has elected life sciences and biopharmaceutical industry veteran Nicolas M. Barthelemy to its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE